These results demonstrated that oral administration of baicalein may suppress T cells including Th2 cells by inducing their differentiation from naive CD4+ T cells to CD4+Foxp3+ Treg cells, thus attenuating food allergy symptoms. This evidence concerns the gene FOXP3 and food allergy.